| 14 mai 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 425 968 | — | |
| 14 mai 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 372 815 | — | |
| 14 mai 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 472 065 | — | |
| 14 mai 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 300 000 | — | |
| 14 mai 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 234 411 | — | |
| 14 mai 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 143 750 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 143 750 | — | |
| 14 mai 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 87 108 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 87 108 | — | |
| 14 mai 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 97 976 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 97 976 | — | |
| 14 mai 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 195 952 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 195 952 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 20 862 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 36 047 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 97 997 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 195 952 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 100 538 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 273 779 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 287 500 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 273 312 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 170 400 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 206 250 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 150 000 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 131 093 | — | deriv |